Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 6
2010 4
2011 11
2012 11
2013 15
2014 14
2015 26
2016 22
2017 13
2018 15
2019 9
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 30275213

122 results
Results by year
Filters applied: . Clear all
Page 1
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, Green RM, Wang HJ, Yong WH, Elashoff R, Cloughesy TF, Lai A. Piccioni DE, et al. Neuro Oncol. 2014 Jun;16(6):815-22. doi: 10.1093/neuonc/nou028. Epub 2014 Mar 13. Neuro Oncol. 2014. PMID: 24627236 Free PMC article.
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
Disseminated progression of glioblastoma after treatment with bevacizumab.
Bloch O, Safaee M, Sun MZ, Butowski NA, McDermott MW, Berger MS, Aghi MK, Parsa AT. Bloch O, et al. Clin Neurol Neurosurg. 2013 Sep;115(9):1795-801. doi: 10.1016/j.clineuro.2013.04.017. Epub 2013 May 21. Clin Neurol Neurosurg. 2013. PMID: 23706614 Free PMC article.
122 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page